Reviewed by the Help Dementia Editorial Team — our editors review every article for accuracy against guidance from the National Institute on Aging, the Alzheimer’s Association, and peer-reviewed sources.
Families sits at the center of this dementia and brain health question.
Families facing an Alzheimer’s diagnosis often feel pressure to start medication immediately, but the right questions can clarify whether medication is actually appropriate for the specific situation. Before starting any Alzheimer’s drug, families should ask: What stage of dementia is this person in? Will this medication address their specific symptoms? What are the actual side effects for someone in their eighties or nineties? How will we know if it’s working? And what happens when we stop? These questions matter because Alzheimer’s medications work differently depending on disease stage, interact unpredictably with other conditions, and produce different results in different people. The decision to start Alzheimer’s medication is not straightforward, even after a diagnosis is confirmed.
A 78-year-old woman with early Alzheimer’s and a history of kidney disease will have a completely different medication experience than a 92-year-old man in moderate dementia with heart problems. The medication that slows cognitive decline slightly in one person may cause dizziness, nausea, or dangerous interactions in another. Starting medication without asking the right questions often leads to side effects that outweigh any benefit, or to continuing a drug long after it stops helping.
Table of Contents
- What Stage of Alzheimer’s Disease Is This, and Does This Medication Work at That Stage?
- What Are the Real Side Effects, and How Might They Interact With Existing Health Conditions?
- What Does “Slowing Cognitive Decline” Actually Mean in Practical Terms?
- What Other Medications Is This Person Taking, and Could Stopping or Adjusting Them Be Helpful Instead?
- What Happens If Side Effects Develop, and When Should We Consider Stopping the Medication?
- How Much Will This Cost, and Is It Covered by Insurance?
- How Often Will We Need to Monitor This Person on Medication, and Who Is Responsible for Adjusting Doses?
What Stage of Alzheimer’s Disease Is This, and Does This Medication Work at That Stage?
alzheimer‘s medications are not one-size-fits-all treatments, and they work best—or only work—at certain disease stages. The cholinesterase inhibitors (donepezil, rivastigmine, and galantamine) and memantine are designed for mild to moderate cognitive decline, not advanced dementia.
Starting a cholinesterase inhibitor in a person who is already in late-stage Alzheimer’s, where they can barely speak or recognize family members, will not reverse their decline and often produces only side effects. Ask the neurologist or doctor: Exactly where does cognitive testing place this person—mild cognitive impairment, mild dementia, moderate, or severe? Which medication is recommended specifically for that stage? One family brought their father in for medication evaluation at what they thought was “early Alzheimer’s,” but testing showed he was already in moderate-stage dementia, making him ineligible for drugs that only slow early decline. The doctor recommended a different approach focused on managing symptoms and safety instead.
What Are the Real Side Effects, and How Might They Interact With Existing Health Conditions?
The side effects of Alzheimer’s medications are not rare inconveniences—they can be serious, especially in older adults. Cholinesterase inhibitors can cause nausea, vomiting, diarrhea, slow heart rate (bradycardia), and syncope (fainting). Memantine can cause dizziness, confusion, and headaches. These side effects are particularly dangerous in people over 80 who already have heart disease, diabetes, or take other medications that interact poorly with Alzheimer’s drugs.
Ask the prescribing doctor: Has anyone reviewed this person’s complete medication list for drug interactions? Do they have a history of slow heart rate, urinary problems, or stomach ulcers—conditions that make cholinesterase inhibitors risky? One 85-year-old man on a beta-blocker for heart disease developed severe bradycardia within a week of starting donepezil and had to be hospitalized when his heart rate dropped to 42 beats per minute. His doctor had not specifically reviewed the interaction. Request a pharmacist review before starting medication, not after side effects develop. Ask whether the potential cognitive benefit—which is often modest—is worth the risk of side effects in this particular person’s health situation.
What Does “Slowing Cognitive Decline” Actually Mean in Practical Terms?
Families often expect Alzheimer’s medications to restore memory or stop dementia entirely. In reality, these medications slow the rate of cognitive decline by an average of 6 to 12 months over two years. This means someone might stay at a certain level of cognitive function a bit longer before declining further, but they will still decline.
The medication is not a cure, and it does not stop the disease progression. Ask the doctor: What specific improvement or outcome would indicate this medication is working? How will we measure that—cognitive testing scores, daily functioning, or symptom reports? Many families realize months into treatment that they don’t actually know what success looks like or how they would recognize it. One daughter expected her mother to remember conversations better, but the medication was actually just slowing the rate at which new memory loss occurred; her mother still forgot new events but perhaps slightly more slowly than she would have without the drug. Set a specific timeline—such as three months—for reassessment, with clear markers for whether to continue the medication.
What Other Medications Is This Person Taking, and Could Stopping or Adjusting Them Be Helpful Instead?
Before starting a new medication, families should ask whether any of the person’s existing medications might be contributing to cognitive symptoms or might be reduced. Many older adults are on medications they no longer need, or medications that actively harm cognition. Benzodiazepines, anticholinergics (including some over-the-counter cold and allergy medicines), and certain blood pressure medications can worsen confusion and memory loss.
Sometimes deprescribing—carefully stopping or reducing these drugs—produces better results than adding an Alzheimer’s medication. Ask the doctor: Has anyone reviewed whether any current medications might be causing or worsening confusion? Are there any medications that could be safely stopped or reduced? Are there over-the-counter medications—sleeping pills, allergy medicines, pain relievers—that this person is taking that might affect cognition? A 79-year-old woman on a nightly over-the-counter antihistamine for allergies, a benzodiazepine for anxiety, and a medication for overactive bladder was prescribed donepezil for memory loss. When her family pushed back and asked about the antihistamine and benzodiazepine, the doctor agreed to discontinue both. Her cognitive function improved noticeably without the new Alzheimer’s drug, suggesting those medications were part of the problem.
What Happens If Side Effects Develop, and When Should We Consider Stopping the Medication?
Starting an Alzheimer’s medication is not a permanent commitment, but families should know the protocol for stopping it if problems arise. Cholinesterase inhibitors can be discontinued abruptly without medical danger, but the decision to stop should be made deliberately with the doctor, not abandoned impulsively. Families should also know that if medication benefits are not apparent after a reasonable trial period—typically three to six months—continuing it may not make sense.
Ask the doctor: What side effects would warrant stopping this medication immediately? What side effects are expected to improve over time, and which ones persist? If side effects develop, how long do we try to manage them before stopping? If there is no noticeable benefit after three months, should we reassess? Some families feel obligated to continue a medication indefinitely, even if it causes suffering and no apparent benefit. One family watched their mother experience nausea and loss of appetite from donepezil, which actually made her weaker and more frail, not sharper. When they asked if stopping was an option, they realized no one had ever discussed when discontinuation would be appropriate.
How Much Will This Cost, and Is It Covered by Insurance?
Alzheimer’s medications vary significantly in cost, and insurance coverage differs by plan and medication type. Donepezil is often available as a generic, making it inexpensive. Rivastigmine and galantamine are available generically but can still be costly. Memantine is available generically.
The newer monoclonal antibodies (aducanumab, lecanemab) are significantly more expensive and have strict insurance requirements. Some insurance plans cover these newer drugs only for early-stage disease or with prior authorization, meaning delays and denials are common. Ask the insurance company and doctor: What is the cost of this specific medication with this person’s insurance? Are there generic alternatives that cost less? Will insurance require prior authorization, and how long does that process take? Some families discover too late that their insurance will not cover the recommended medication, or requires a three-week authorization process that delays treatment. Understanding cost upfront prevents surprises and helps families decide whether the medication is worth the expense if it is not covered.
How Often Will We Need to Monitor This Person on Medication, and Who Is Responsible for Adjusting Doses?
Starting Alzheimer’s medication creates an ongoing monitoring obligation. Doses typically must be increased gradually over weeks to minimize side effects, requiring regular follow-up visits.
Some medications require regular lab testing—for example, liver function monitoring—adding to the medical burden. Families should understand who manages this follow-up and what happens if side effects or complications arise. Ask the prescribing doctor: What is the dosing schedule, and when will doses be increased? How frequently does this person need to be seen for follow-up—weekly, monthly, quarterly? Are there any lab tests needed while on this medication? Who should be contacted if side effects develop, and how quickly can adjustments be made? One family started their mother on a medication, received dosing instructions, and then heard nothing from the doctor’s office for two months, forcing them to chase the clinic to request the promised follow-up appointment and dose adjustment.
You Might Also Like
- Can Families Help Track Alzheimer’s Treatment Effects?
- Can Families Help Track Alzheimer’s Treatment Effects?
- What Families Should Know About AI Dementia Tools
For more, see NIH MedlinePlus — cognitive testing.
